SCHEMBL23959288

SCHEMBL23959288

CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc(-c2ccn3c(-c4ccccc4)c(-c4ccccc4)nc3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 10/20 0.48
▸ AKT2 P31751 9/20 0.48
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPK13 O15264 4/20 0.35
▸ MAPK12 P53778 4/20 0.35
▸ MAPK11 Q15759 4/20 0.35
▸ MAPK14 Q16539 4/20 0.35
▸ ADORA2A P29274 1/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ MGAM O43451 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ SI P14410 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959281 0.98 AKT1 (0.47) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959280 0.88 AKT1 (0.53) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959306 0.88 AKT1 (0.50) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959285 0.86 AKT1 (0.51) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959318 0.86 AKT1 (0.51) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959312 0.86 AKT1 (0.37) AKT1AKT2MAPK13MAPK12MAPK11
SCHEMBL23959317 0.85 AKT1 (0.50) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959308 0.85 AKT1 (0.56) AKT1AKT2MEN1USP2HPGD
SCHEMBL23959311 0.84 AKT1 (0.40) AKT1AKT2MAPK13MAPK12MAPK11
SCHEMBL23959289 0.83 AKT1 (0.48) AKT1AKT2MEN1USP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback